Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T 1H MRS imaging study

被引:70
作者
Mathew, Sanjay J. [2 ]
Mao, Xiangling [1 ]
Keegan, Kathryn A. [2 ]
Levine, Susan M.
Smith, Eric L. P. [3 ]
Heier, Linda A. [1 ]
Otcheretko, Viktor [2 ]
Coplan, Jeremy D. [3 ]
Shungu, Dikoma C. [1 ]
机构
[1] Cornell Univ, Weill Med Coll, Citigrp Biomed Imaging Ctr, Dept Radiol, New York, NY 10021 USA
[2] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA
[3] SUNY Hlth Sci Ctr, Dept Psychiat, Brooklyn, NY 11203 USA
关键词
MRS; lactate; brain metabolism; chronic fatigue syndrome; anxiety disorder; cerebrospinal fluid; MAGNETIC-RESONANCE-SPECTROSCOPY; OXIDATIVE STRESS; NMR-SPECTROSCOPY; BLOOD-FLOW; BRAIN; PREVALENCE; MELAS; DEFINITION; METABOLISM; DEPRESSION;
D O I
10.1002/nbm.1315
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Chronic fatigue syndrome (CFS) is a controversial diagnosis because of the lack of biomarkers for the illness and its symptom overlap with neuropsychiatric, infectious, and rheumatological disorders. We compared lateral ventricular volumes derived from tissue-segmented T-1-weighted volumetric MRI data and cerebrospinal fluid (CSF) lactate concentrations measured by proton MRS imaging (H-1 MRSI) in 16 subjects with CFS (modified US Centers for Disease Control and Prevention criteria) with those in 14 patients with generalized anxiety disorder (GAD) and in 15 healthy volunteers, matched group-wise for age, sex, body mass index, handedness, and IQ. Mean lateral ventricular lactate concentrations measured by H-1 MRSI in CFS were increased by 297% compared with those in GAD (P < 0.001) and by 348% compared with those in healthy volunteers (P < 0.001), even after controlling for ventricular volume, which did not differ significantly between the groups. Regression analysis revealed that diagnosis accounted for 43% of the variance in ventricular lactate. CFS is associated with significantly raised concentrations of ventricular lactate, potentially consistent with recent evidence of decreased cortical blood flow, secondary mitochondrial dysfunction, and/or oxidative stress abnormalities in the disorder. (C) Copyright 0 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:251 / 258
页数:8
相关论文
共 44 条
[41]  
WATSON MA, 1995, CLIN CHEM, V41, P343
[42]   Reduction of serotonin transporters of patients with chronic fatigue syndrome [J].
Yamamoto, S ;
Ouchi, Y ;
Onoe, H ;
Yoshikawa, E ;
Tsukada, H ;
Takahashi, H ;
Iwase, M ;
Yamaguti, K ;
Kuratsune, H ;
Watanabe, Y .
NEUROREPORT, 2004, 15 (17) :2571-2574
[43]   Patients with chronic fatigue syndrome have reduced absolute cortical blood flow [J].
Yoshiuchi, K ;
Farkas, J ;
Natelson, BH .
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2006, 26 (02) :83-86
[44]   Mitochondrial inhibition and oxidative stress: Reciprocating players in neurodegeneration [J].
Zeevalk, GD ;
Bernard, LP ;
Song, C ;
Gluck, M ;
Ehrhart, J .
ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (9-10) :1117-1139